TAZOBACTAM SODIUM

BACTERIOSTATIC ANTIBACTERIAL

ANTIBIOTIC

ANTIBIOTIC

ANTIBIOTIC

Human and veterinary use. Effective anthelmintic against parasitic infestations caused by Enterobius vermicularis (pinworms), Ascaris lumbricoides (ascaridiasis), Ancylostoma duodenale and Necator americanus (uncinariasis) and Trichostrongylus colubriformis and orientalis (trichostrongliasis). It also...

Human use. Topical sulfonamides alone.  It is indicated for the treatment and prevention of infections in second and third degree burns, as well as varicose and decubitus ulcers.

ANTIBIOTIC

Antibiotic

ANTIEMETIC

ANTIHYPERTENSIVE

ANTIBIOTIC

ANTIBIOTIC

In the rapidly evolving landscape of pharmaceutical manufacturing, the TT&GO® platform by Suanfarma CDMO stands out as a revolutionary solution for technology transfer. This session will explore into the unique methodology of TT&GO®, which integrates rigorous, systematic procedures grounded in risk-based analysis to facilitate seamless technology transfers. Methodological rigor and flexibility: Understanding the systematic approach of TT&GO® that applies to various phases of the product lifecycle, ensuring adaptability and compliance with Good Manufacturing Practices (GMP). Risk management and cost efficiency: Analyzing how TT&GO®'s proactive risk assessment and mitigation strategies lead to reduced failure rates and cost savings, empowering clients to pursue ambitious project timelines with minimized risks. Real-world applications and outcomes: Presenting case studies and success stories of TT&GO® in action, highlighting the platform's impact on accelerating commercial launches and enhancing market competitiveness. Attendees of this session can expect to leave with a comprehensive understanding of how advanced technology transfer methodologies like TT&GO® can be leveraged to optimize pharmaceutical manufacturing processes, ensuring higher efficiency, reduced risk, and better overall outcomes.

Suanfarma is a key player in the life sciences sector, specializing in the development of active pharmaceutical ingredients (APIs) and contract development and manufacturing (CDMO) services. Since 1993, Suanfarma has been dedicated to enhancing global health by improving access to affordable medicines. We operate advanced facilities in Portugal and Italy, and supports over 400 laboratories worldwide through a robust network of 12 commercial offices.

Suanfarma’s proprietary APIs are developed using cutting-edge techniques, including AI and Flow Chemistry, ensuring high standards and GMP compliance. We are committed to sustainability and global health, offering innovative solutions for High Potency APIs and expanding fermentation and chemical synthesis capacities to meet growing global demand. 

Our customer-centric approach and strong focus on quality makes us a trusted partner in the pharmaceutical industry.

...